| DIRECT COMPETITOR COMPARISON | |
| LH | BRLI | Pvt1 | DGX | Industry | | Market Cap: | 7.78B | 446.37M | N/A | 10.77B | 78.88M | | Employees: | 28,000 | 1,484 | 1,1001 | 42,800 | 474 | | Qtrly Rev Growth (yoy): | 4.40% | 25.30% | N/A | 3.90% | 13.50% | | Revenue (ttm): | 4.65B | 341.58M | 105.00M1 | 7.41B | 141.20M | | Gross Margin (ttm): | 41.84% | 51.23% | N/A | 42.16% | 47.15% | | EBITDA (ttm): | 1.11B | 44.47M | N/A | 1.61B | 8.84M | | Oper Margins (ttm): | 20.38% | 10.27% | N/A | 18.18% | 7.12% | | Net Income (ttm): | 518.70M | 19.91M | N/A | 717.54M | N/A | | EPS (ttm): | 4.771 | 1.430 | N/A | 3.774 | 0.03 | | P/E (ttm): | 15.36 | 22.57 | N/A | 15.44 | 23.48 | | PEG (5 yr expected): | 1.28 | 1.22 | N/A | 1.22 | 1.44 | | P/S (ttm): | 1.70 | 1.32 | N/A | 1.47 | 1.78 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | DGX | | ETF Sector Detector: Getting More Defensive
Wed, Nov 25 -
at Seeking Alpha | | • | DGX | | Feds seek rehearing of baseball drug list ruling
Wed, Nov 25 -
AP | | • | DGX | | Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference
Tue, Nov 24 -
PR Newswire | | • | DGX | | Swine flu may have hit one peak; more to come
Fri, Nov 20 -
at Reuters | | • | DGX | | UPDATE - Swine flu may be peaking in US, reports indicate
Fri, Nov 20 -
at Reuters | | • | DGX | | H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics
Fri, Nov 20 -
PR Newswire | | • | BRLI | | Bio-Reference Laboratories, Inc. Again Awarded New York State Department of Corrections Laboratory Services Contract
Thu, Nov 5 -
Business Wire | | • | BRLI | | SmallCapSentinel.com: Records and Revenues
Tue, Nov 3 -
GlobeNewswire | | • | BRLI | | 5-Star Stocks on the Upswing
Mon, Nov 2 -
at Motley Fool | | • | BRLI | | BioReference Laboratories, Inc to Speak at the Oppenheimer 20th Annual Health Care Conference
Tue, Oct 27 -
Business Wire | | • | BRLI | | In Depth: Self-Made Stars
Wed, Oct 14 -
at Forbes.com | | | All Headlines for these symbols... |
|
|
|
1.48% Nasdaq 
Competitors
